Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies

Clinical trial NCT00038051 · COMPLETED

Trial details

NCT number: NCT00038051
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Myeloproliferative Disorders Anemia, Refractory, With Excess of Blasts

Start date: 1999-05-01
Primary completion: 2013-02-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.